YJ13的个人主页 - 老虎社区

YJ13

暂无个人介绍

IP属地：未知

19关注

9粉丝

0主题

0勋章

2021-10-19

Good good

抱歉，原内容已删除

2021-10-05

Good

Chief Studios Officer Of Electronic Arts Sold $440K In Stock<blockquote>Electronic Arts首席工作室官出售44万美元库存</blockquote>

2021-10-20

[微笑]

抱歉，原内容已删除

2021-11-12

Buy?

Disney shares fell more than 8% in morning trading<blockquote>迪士尼股价早盘下跌逾8%</blockquote>

2021-11-02

Good

抱歉，原内容已删除

2021-10-19

Pk

抱歉，原内容已删除

2022-01-10

Good

Semiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote>

2021-11-20

Good

抱歉，原内容已删除

2021-10-26

Good

抱歉，原内容已删除

2021-11-14

Buy?

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3583202487304124","uuid":"3583202487304124","gmtCreate":1620108463275,"gmtModify":1744616402376,"name":"YJ13","pinyin":"yj13","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":19,"tweetSize":40,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.25","exceedPercentage":"93.77%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.05","exceedPercentage":"93.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":633416618,"gmtCreate":1644281711895,"gmtModify":1644281712058,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633416618","repostId":"1136151280","repostType":2,"isVote":1,"tweetType":1,"viewCount":4211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633220155,"gmtCreate":1644145611640,"gmtModify":1644145611770,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633220155","repostId":"1105432695","repostType":4,"isVote":1,"tweetType":1,"viewCount":3254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633220313,"gmtCreate":1644145532580,"gmtModify":1644145536323,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633220313","repostId":"2209347958","repostType":4,"isVote":1,"tweetType":1,"viewCount":3132,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633220923,"gmtCreate":1644145480669,"gmtModify":1644145480843,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633220923","repostId":"1123525144","repostType":4,"isVote":1,"tweetType":1,"viewCount":3362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633667654,"gmtCreate":1644020615129,"gmtModify":1644020615653,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633667654","repostId":"1173208136","repostType":2,"isVote":1,"tweetType":1,"viewCount":2646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633812247,"gmtCreate":1643930540415,"gmtModify":1643930540547,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633812247","repostId":"1103202380","repostType":2,"repost":{"id":"1103202380","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643927591,"share":"https://www.laohu8.com/m/news/1103202380?lang=zh_CN&edition=full","pubTime":"2022-02-04 06:33","market":"us","language":"zh","title":"盘后大涨逾18%！亚马逊Q4净利润同比增长98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103202380","media":"老虎资讯综合","summary":"2月4日，亚马逊发布2021年第四季度及全年业绩。财报显示，第四季度营收1374亿美元，市场预期1375.53亿美元，去年同期1255.55亿美元；第四季度净利润143.23亿美元，市场预期19.26","content":"<html><head></head><body><p>2月4日，<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>发布2021年第四季度及全年业绩。财报显示，第四季度营收1374亿美元，市场预期1375.53亿美元，去年同期1255.55亿美元；第四季度净利润143.23亿美元，市场预期19.26亿美元，去年同期72.22亿美元；第四季度每股收益27.75美元，市场预期3.55美元，去年同期14.09美元。</p><p><img src=\"https://static.tigerbbs.com/87a4933df0f8d6648a2fb161f1e93983\" tg-width=\"772\" tg-height=\"743\" referrerpolicy=\"no-referrer\"/></p><p>财报发布后，亚马逊盘后股价一度大涨逾18%。</p><p><img src=\"https://static.tigerbbs.com/ba8b6ef84dbeec1a5bd3ae6e90b59c98\" tg-width=\"889\" tg-height=\"823\" referrerpolicy=\"no-referrer\"/></p><p><b>第四季度主要业绩：</b></p><p>在截至12月31日的这一财季，亚马逊的净利润为143.23亿美元，每股摊薄收益27.75美元，这一业绩好于上年同期。2020财年第四季度，亚马逊的净利润为72.22亿美元，每股摊薄收益14.09美元。</p><p>亚马逊第四季度运营利润为34.60亿美元，相比之下上年同期为68.73亿美元。</p><p>亚马逊第四季度净销售额为1374.12亿美元，与上年同期的1255.55亿美元相比增长9%。不计入汇率变动所带来的13亿美元的负面影响，亚马逊第四季度净销售额与上年同期相比增长10%。</p><p>亚马逊第四季度每股收益超出华尔街分析师预期，但营收略微不及预期。据<a href=\"https://laohu8.com/S/YHOO\">雅虎</a>财经统计的数据显示，41名分析师此前平均预期亚马逊第四季度每股收益将达3.58美元，40名分析师平均预期亚马逊第四季度净销售额将达1375.6亿美元。</p><p><b>现金流数据：</b></p><p>在截至2021年12月31日的12个月时间里，亚马逊的运营现金流为463亿美元，比上年同期下降30%；在截至2020年12月31日的12个月时间里，亚马逊的运营现金流为661亿美元。</p><p>在截至2021年12月31日的12个月时间里，亚马逊的自由现金流为91亿美元，低于上年同期；在截至2020年12月31日的12个月时间里，亚马逊的自由现金流为310亿美元。</p><p>在扣除租约本金还款以后，亚马逊过去12个月时间里的自由现金流为流出204亿美元；在截至2020年12月31日的12个月时间里，亚马逊扣除前述项目以后的自由现金流为流入203亿美元。</p><p>在扣除融资租赁本金还款以及根据资本租约所获资产以后，亚马逊过去12个月时间里的自由现金流为流出143亿美元；相比之下，在截至2020年12月31日的12个月时间里，亚马逊扣除前述项目以后的自由现金流为流入214亿美元。</p><p><b>第四季度财务分析：</b></p><p>亚马逊第四季度产品净销售额为714.16亿美元，相比之下上年同期为710.56亿美元；服务净销售额为659.96亿美元，相比之下上年同期为544.99亿美元。</p><p>去年10月，亚该公司2021财年第四季度的净销售额将达1300亿美元到1400亿美元，同比增长4%到12%，其中包含了汇率变动预计将会带来的约60个基点的负面影响，其平均值为1350亿美元，不及分析师当时预期。亚马逊还在当时预计，2021财年第四季度运营利润将在零到30亿美元之间，相比之下2020年同期运营利润为69亿美元。</p><p>按照地域划分，亚马逊北美部门（美国、加拿大）第四季度净销售额为823.60亿美元，与上年同期的753.46亿美元相比增长9%；运营亏损为2.06亿美元，相比之下上年同期的运营利润为29.46亿美元。</p><p>亚马逊国际部门（英国、德国、法国、日本和中国）第四季度净销售额为372.72亿美元，与上年同期的374.67亿美元相比下降1%；运营亏损为16.27亿美元，相比之下全年上年同期的运营利润为3.63亿美元。</p><p>亚马逊第四季度来自于北美部门的销售额在总销售额中所占比例为60%，与上年同期相比持平；来自于国际部门的销售额在总销售额中所占比例为270%，低于上年同期的3%。</p><p>亚马逊AWS云服务第四季度净销售额为177.80亿美元，与上年同期的127.42亿美元相比增长40%；运营利润为52.93亿美元，相比之下上年同期为35.64亿美元。</p><p>来自于AWS云服务的销售额在总销售额中所占比例为13%，高于上年同期的10%。</p><p>按照服务和业务类型划分，亚马逊第二季度来自于在线商店的净销售额为660.75亿美元，与上年同期的664.51亿美元相比下降1%，不计入汇率变动的影响为同比增长1%；</p><p>来自于实体店的净销售额为46.88亿美元，与上年同期的40.22亿美元相比增长17%，不计入汇率变动的影响为同比增长16%；</p><p>来自于第三方卖家服务的净销售额为303.20亿美元，与上年同期的273.27亿美元相比增长11%，不计入汇率变动的影响为同比增长12%；</p><p>来自于订阅服务的净销售额为81.23亿美元，与上年同期的70.61亿美元相比增长15%，不计入汇率变动的影响为同比增长16%；</p><p>来自于广告服务的营收为97.16亿美元，与上年同期的73.50亿美元相比增长32%，不计入汇率变动的影响为同比增长33%；</p><p>来自于AWS云服务的净销售额为177.80亿美元，与上年同期的127.42亿美元相比增长40%，不计入汇率变动的影响同样为同比增长40%；</p><p>来自于其他业务的净销售额为7.10亿美元，与上年同期的6.02亿美元相比增长18%，不计入汇率变动的影响为同比增长19%。</p><p><b>2021财年主要业绩：</b></p><p>在整个2021财年，亚马逊的净销售额为4698亿美元，与2020财年的3861亿美元相比增长22%；不计入汇率变动所带来的38亿美元的正面影响，亚马逊2021财年净销售额同比增长21%。</p><p>亚马逊2021财年运营利润为249亿美元，相比之下2020财年为229亿美元。</p><p>亚马逊2021财年净利润为334亿美元，每股收益为64.81美元，相比之下2020财年净利润为213亿美元，每股收益为41.83美元。</p><p><b>业绩预期：</b></p><p>亚马逊预计2022财年第一季度净销售额将达1120亿美元到1170亿美元之间，同比增长3%到8%，其中包含了汇率变动预计将可带来的约150个基点的负面影响。</p><p>亚马逊还预计，2022财年第一季度运营利润将达30亿美元到60亿美元之间，相比之下2020财年同期的运营利润为89亿美元。</p><p>亚马逊对第一季度净销售额预期区间的中值为1145亿美元，不及分析师预期。据雅虎财经统计的数据显示，31名分析师此前平均预期亚马逊第一季度净销售额将达1201.1亿美元。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘后大涨逾18%！亚马逊Q4净利润同比增长98%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘后大涨逾18%！亚马逊Q4净利润同比增长98%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2022-02-04 06:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>2月4日，<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>发布2021年第四季度及全年业绩。财报显示，第四季度营收1374亿美元，市场预期1375.53亿美元，去年同期1255.55亿美元；第四季度净利润143.23亿美元，市场预期19.26亿美元，去年同期72.22亿美元；第四季度每股收益27.75美元，市场预期3.55美元，去年同期14.09美元。</p><p><img src=\"https://static.tigerbbs.com/87a4933df0f8d6648a2fb161f1e93983\" tg-width=\"772\" tg-height=\"743\" referrerpolicy=\"no-referrer\"/></p><p>财报发布后，亚马逊盘后股价一度大涨逾18%。</p><p><img src=\"https://static.tigerbbs.com/ba8b6ef84dbeec1a5bd3ae6e90b59c98\" tg-width=\"889\" tg-height=\"823\" referrerpolicy=\"no-referrer\"/></p><p><b>第四季度主要业绩：</b></p><p>在截至12月31日的这一财季，亚马逊的净利润为143.23亿美元，每股摊薄收益27.75美元，这一业绩好于上年同期。2020财年第四季度，亚马逊的净利润为72.22亿美元，每股摊薄收益14.09美元。</p><p>亚马逊第四季度运营利润为34.60亿美元，相比之下上年同期为68.73亿美元。</p><p>亚马逊第四季度净销售额为1374.12亿美元，与上年同期的1255.55亿美元相比增长9%。不计入汇率变动所带来的13亿美元的负面影响，亚马逊第四季度净销售额与上年同期相比增长10%。</p><p>亚马逊第四季度每股收益超出华尔街分析师预期，但营收略微不及预期。据<a href=\"https://laohu8.com/S/YHOO\">雅虎</a>财经统计的数据显示，41名分析师此前平均预期亚马逊第四季度每股收益将达3.58美元，40名分析师平均预期亚马逊第四季度净销售额将达1375.6亿美元。</p><p><b>现金流数据：</b></p><p>在截至2021年12月31日的12个月时间里，亚马逊的运营现金流为463亿美元，比上年同期下降30%；在截至2020年12月31日的12个月时间里，亚马逊的运营现金流为661亿美元。</p><p>在截至2021年12月31日的12个月时间里，亚马逊的自由现金流为91亿美元，低于上年同期；在截至2020年12月31日的12个月时间里，亚马逊的自由现金流为310亿美元。</p><p>在扣除租约本金还款以后，亚马逊过去12个月时间里的自由现金流为流出204亿美元；在截至2020年12月31日的12个月时间里，亚马逊扣除前述项目以后的自由现金流为流入203亿美元。</p><p>在扣除融资租赁本金还款以及根据资本租约所获资产以后，亚马逊过去12个月时间里的自由现金流为流出143亿美元；相比之下，在截至2020年12月31日的12个月时间里，亚马逊扣除前述项目以后的自由现金流为流入214亿美元。</p><p><b>第四季度财务分析：</b></p><p>亚马逊第四季度产品净销售额为714.16亿美元，相比之下上年同期为710.56亿美元；服务净销售额为659.96亿美元，相比之下上年同期为544.99亿美元。</p><p>去年10月，亚该公司2021财年第四季度的净销售额将达1300亿美元到1400亿美元，同比增长4%到12%，其中包含了汇率变动预计将会带来的约60个基点的负面影响，其平均值为1350亿美元，不及分析师当时预期。亚马逊还在当时预计，2021财年第四季度运营利润将在零到30亿美元之间，相比之下2020年同期运营利润为69亿美元。</p><p>按照地域划分，亚马逊北美部门（美国、加拿大）第四季度净销售额为823.60亿美元，与上年同期的753.46亿美元相比增长9%；运营亏损为2.06亿美元，相比之下上年同期的运营利润为29.46亿美元。</p><p>亚马逊国际部门（英国、德国、法国、日本和中国）第四季度净销售额为372.72亿美元，与上年同期的374.67亿美元相比下降1%；运营亏损为16.27亿美元，相比之下全年上年同期的运营利润为3.63亿美元。</p><p>亚马逊第四季度来自于北美部门的销售额在总销售额中所占比例为60%，与上年同期相比持平；来自于国际部门的销售额在总销售额中所占比例为270%，低于上年同期的3%。</p><p>亚马逊AWS云服务第四季度净销售额为177.80亿美元，与上年同期的127.42亿美元相比增长40%；运营利润为52.93亿美元，相比之下上年同期为35.64亿美元。</p><p>来自于AWS云服务的销售额在总销售额中所占比例为13%，高于上年同期的10%。</p><p>按照服务和业务类型划分，亚马逊第二季度来自于在线商店的净销售额为660.75亿美元，与上年同期的664.51亿美元相比下降1%，不计入汇率变动的影响为同比增长1%；</p><p>来自于实体店的净销售额为46.88亿美元，与上年同期的40.22亿美元相比增长17%，不计入汇率变动的影响为同比增长16%；</p><p>来自于第三方卖家服务的净销售额为303.20亿美元，与上年同期的273.27亿美元相比增长11%，不计入汇率变动的影响为同比增长12%；</p><p>来自于订阅服务的净销售额为81.23亿美元，与上年同期的70.61亿美元相比增长15%，不计入汇率变动的影响为同比增长16%；</p><p>来自于广告服务的营收为97.16亿美元，与上年同期的73.50亿美元相比增长32%，不计入汇率变动的影响为同比增长33%；</p><p>来自于AWS云服务的净销售额为177.80亿美元，与上年同期的127.42亿美元相比增长40%，不计入汇率变动的影响同样为同比增长40%；</p><p>来自于其他业务的净销售额为7.10亿美元，与上年同期的6.02亿美元相比增长18%，不计入汇率变动的影响为同比增长19%。</p><p><b>2021财年主要业绩：</b></p><p>在整个2021财年，亚马逊的净销售额为4698亿美元，与2020财年的3861亿美元相比增长22%；不计入汇率变动所带来的38亿美元的正面影响，亚马逊2021财年净销售额同比增长21%。</p><p>亚马逊2021财年运营利润为249亿美元，相比之下2020财年为229亿美元。</p><p>亚马逊2021财年净利润为334亿美元，每股收益为64.81美元，相比之下2020财年净利润为213亿美元，每股收益为41.83美元。</p><p><b>业绩预期：</b></p><p>亚马逊预计2022财年第一季度净销售额将达1120亿美元到1170亿美元之间，同比增长3%到8%，其中包含了汇率变动预计将可带来的约150个基点的负面影响。</p><p>亚马逊还预计，2022财年第一季度运营利润将达30亿美元到60亿美元之间，相比之下2020财年同期的运营利润为89亿美元。</p><p>亚马逊对第一季度净销售额预期区间的中值为1145亿美元，不及分析师预期。据雅虎财经统计的数据显示，31名分析师此前平均预期亚马逊第一季度净销售额将达1201.1亿美元。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3473f757d00eee50292777a0505620c4","relate_stocks":{"AMZN":"亚马逊"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103202380","content_text":"2月4日，亚马逊发布2021年第四季度及全年业绩。财报显示，第四季度营收1374亿美元，市场预期1375.53亿美元，去年同期1255.55亿美元；第四季度净利润143.23亿美元，市场预期19.26亿美元，去年同期72.22亿美元；第四季度每股收益27.75美元，市场预期3.55美元，去年同期14.09美元。财报发布后，亚马逊盘后股价一度大涨逾18%。第四季度主要业绩：在截至12月31日的这一财季，亚马逊的净利润为143.23亿美元，每股摊薄收益27.75美元，这一业绩好于上年同期。2020财年第四季度，亚马逊的净利润为72.22亿美元，每股摊薄收益14.09美元。亚马逊第四季度运营利润为34.60亿美元，相比之下上年同期为68.73亿美元。亚马逊第四季度净销售额为1374.12亿美元，与上年同期的1255.55亿美元相比增长9%。不计入汇率变动所带来的13亿美元的负面影响，亚马逊第四季度净销售额与上年同期相比增长10%。亚马逊第四季度每股收益超出华尔街分析师预期，但营收略微不及预期。据雅虎财经统计的数据显示，41名分析师此前平均预期亚马逊第四季度每股收益将达3.58美元，40名分析师平均预期亚马逊第四季度净销售额将达1375.6亿美元。现金流数据：在截至2021年12月31日的12个月时间里，亚马逊的运营现金流为463亿美元，比上年同期下降30%；在截至2020年12月31日的12个月时间里，亚马逊的运营现金流为661亿美元。在截至2021年12月31日的12个月时间里，亚马逊的自由现金流为91亿美元，低于上年同期；在截至2020年12月31日的12个月时间里，亚马逊的自由现金流为310亿美元。在扣除租约本金还款以后，亚马逊过去12个月时间里的自由现金流为流出204亿美元；在截至2020年12月31日的12个月时间里，亚马逊扣除前述项目以后的自由现金流为流入203亿美元。在扣除融资租赁本金还款以及根据资本租约所获资产以后，亚马逊过去12个月时间里的自由现金流为流出143亿美元；相比之下，在截至2020年12月31日的12个月时间里，亚马逊扣除前述项目以后的自由现金流为流入214亿美元。第四季度财务分析：亚马逊第四季度产品净销售额为714.16亿美元，相比之下上年同期为710.56亿美元；服务净销售额为659.96亿美元，相比之下上年同期为544.99亿美元。去年10月，亚该公司2021财年第四季度的净销售额将达1300亿美元到1400亿美元，同比增长4%到12%，其中包含了汇率变动预计将会带来的约60个基点的负面影响，其平均值为1350亿美元，不及分析师当时预期。亚马逊还在当时预计，2021财年第四季度运营利润将在零到30亿美元之间，相比之下2020年同期运营利润为69亿美元。按照地域划分，亚马逊北美部门（美国、加拿大）第四季度净销售额为823.60亿美元，与上年同期的753.46亿美元相比增长9%；运营亏损为2.06亿美元，相比之下上年同期的运营利润为29.46亿美元。亚马逊国际部门（英国、德国、法国、日本和中国）第四季度净销售额为372.72亿美元，与上年同期的374.67亿美元相比下降1%；运营亏损为16.27亿美元，相比之下全年上年同期的运营利润为3.63亿美元。亚马逊第四季度来自于北美部门的销售额在总销售额中所占比例为60%，与上年同期相比持平；来自于国际部门的销售额在总销售额中所占比例为270%，低于上年同期的3%。亚马逊AWS云服务第四季度净销售额为177.80亿美元，与上年同期的127.42亿美元相比增长40%；运营利润为52.93亿美元，相比之下上年同期为35.64亿美元。来自于AWS云服务的销售额在总销售额中所占比例为13%，高于上年同期的10%。按照服务和业务类型划分，亚马逊第二季度来自于在线商店的净销售额为660.75亿美元，与上年同期的664.51亿美元相比下降1%，不计入汇率变动的影响为同比增长1%；来自于实体店的净销售额为46.88亿美元，与上年同期的40.22亿美元相比增长17%，不计入汇率变动的影响为同比增长16%；来自于第三方卖家服务的净销售额为303.20亿美元，与上年同期的273.27亿美元相比增长11%，不计入汇率变动的影响为同比增长12%；来自于订阅服务的净销售额为81.23亿美元，与上年同期的70.61亿美元相比增长15%，不计入汇率变动的影响为同比增长16%；来自于广告服务的营收为97.16亿美元，与上年同期的73.50亿美元相比增长32%，不计入汇率变动的影响为同比增长33%；来自于AWS云服务的净销售额为177.80亿美元，与上年同期的127.42亿美元相比增长40%，不计入汇率变动的影响同样为同比增长40%；来自于其他业务的净销售额为7.10亿美元，与上年同期的6.02亿美元相比增长18%，不计入汇率变动的影响为同比增长19%。2021财年主要业绩：在整个2021财年，亚马逊的净销售额为4698亿美元，与2020财年的3861亿美元相比增长22%；不计入汇率变动所带来的38亿美元的正面影响，亚马逊2021财年净销售额同比增长21%。亚马逊2021财年运营利润为249亿美元，相比之下2020财年为229亿美元。亚马逊2021财年净利润为334亿美元，每股收益为64.81美元，相比之下2020财年净利润为213亿美元，每股收益为41.83美元。业绩预期：亚马逊预计2022财年第一季度净销售额将达1120亿美元到1170亿美元之间，同比增长3%到8%，其中包含了汇率变动预计将可带来的约150个基点的负面影响。亚马逊还预计，2022财年第一季度运营利润将达30亿美元到60亿美元之间，相比之下2020财年同期的运营利润为89亿美元。亚马逊对第一季度净销售额预期区间的中值为1145亿美元，不及分析师预期。据雅虎财经统计的数据显示，31名分析师此前平均预期亚马逊第一季度净销售额将达1201.1亿美元。","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":2936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697664458,"gmtCreate":1642464214672,"gmtModify":1642464216126,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697664458","repostId":"1133140064","repostType":2,"repost":{"id":"1133140064","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642460381,"share":"https://www.laohu8.com/m/news/1133140064?lang=zh_CN&edition=full","pubTime":"2022-01-18 06:59","market":"hk","language":"zh","title":"昨夜今晨：大型科技公司面临新一轮监管潮！国际大行董事长辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=1133140064","media":"老虎资讯综合","summary":"报告显示由于新冠肺炎疫情对全球劳动力市场产生重大影响，2022年全球复苏将缓慢且不确定。南太平洋岛国汤加海域发生大规模火山爆发。公司新闻美国大型科技公司面临新一轮监管潮！瑞士第二大银行瑞士信贷董事长辞职，曾两次违反新冠防疫规定瑞士信贷银行董事长安东尼奥·奥尔塔-奥索里奥17日辞职，原因是违反了新冠疫情隔离规定。","content":"<html><head></head><body><blockquote><b>摘要：</b>因马丁路德金纪念日假期影响，美股周一休市一天；布油触及逾三年新高，美油升破84美元至两个月高位；黄金尝试上破1820美元；苹果被迫放宽支付规定，荷兰监管机构：将审查整改措施；瑞信风波不断！董事长因违反防疫规定下台&gt;&gt;&gt;</blockquote><p><b>国际市场</b></p><p><b>1月17日因马丁·路德·金纪念日，美股休市一天</b></p><p>1月17日（周一）为“马丁·路德·金纪念日”，美股休市一天，1月18日（周二）恢复正常交易。</p><p><b>欧股全线收涨，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数涨0.91%</b></p><p>德国DAX30指数涨0.34%，法国CAC40指数涨0.82%，英国<a href=\"https://laohu8.com/S/.100.UK\">富时100指数</a>涨0.91%，西班牙IBEX35指数涨0.38%，意大利富时MIB指数涨0.5%，欧洲斯托克50指数涨0.74%。</p><p><b>国际原油期货结算价小幅收涨，布油涨0.49%</b></p><p>国际原油期货结算价小幅收涨，布伦特3月原油期货结算价收涨0.42美元，涨幅0.49%，报86.48美元/桶。</p><p><b>金价持稳，投资者在加息前景和Omicron威胁之间进行权衡</b></p><p>黄金价格在创下两个月来最佳单周涨幅后企稳，交易员在货币政策前景和美国新一轮冠状病毒疫情构成的威胁之间进行权衡。黄金价格保持在每盎司1800美元上方，此前金价2021年录得三年来首次下跌，因投资者开始反映货币政策收紧。</p><p><b>国际宏观</b></p><p><a href=\"https://laohu8.com/NW/2204774519\" target=\"_blank\"><b>福奇：尚且无法断言奥密克戎变异株标志着大流行病的结束</b></a></p><p>美国总统首席医学顾问安东尼·福奇博士表示，现在尚且无法断言奥密克戎变异株将标志着新冠疫情从大流行病演变为地方性流行病。“奥密克戎是否会是大家都希望的活病毒疫苗，这是一个悬而未决的问题，因为随着新的变异株的出现，有着很多的可变性，”福奇周一在世界经济论坛的达沃斯议程在线会议上表示。</p><p><a href=\"https://laohu8.com/NW/2204774519\" target=\"_blank\"><b>达利欧警告：通胀恐慌之际，脱离化石燃料不能操之过急</b></a></p><p>对冲基金桥水创始人瑞·达利欧警告称，脱离化石燃料的转型过程不能太快，并表示，通胀飙升之际，停止向该行业供应资金将会产生破坏稳定的效应。</p><p><b>国际劳工组织下调2022年全球劳动力市场复苏预测</b></p><p>总部位于瑞士日内瓦的国际劳工组织发布《世界就业和社会展望2022年趋势》报告。报告显示由于新冠肺炎疫情对全球劳动力市场产生重大影响，2022年全球复苏将缓慢且不确定。</p><p><b>欧元区国家财长会议同意对各国减债计划作出新安排</b></p><p>欧元区19国财政部长当地时间17日在欧盟总部布鲁塞尔举行会议，重点讨论了如何修改欧洲《稳定与增长公约》中关于政府债务上限的条款。欧盟委员会副主席东布罗斯基斯当天会后表示，各国基本同意修改原公约中比较严格的条款，而采取更符合实际也更可操作的办法。</p><p><b>17日美国东部超过5000万人收到冬季风暴警报</b></p><p>据美国有线电视新闻网（CNN）当地时间1月17日报道，冬季风暴持续侵袭美国东部，17日早间已经有超过5000万人收到风暴相关的极端天气警报。风暴带来的龙卷风、冻雨和大雪也席卷了从佛罗里达州到缅因州的部分地区。受风暴影响，航班取消和各地断电的问题也依旧严峻。</p><p><a href=\"https://laohu8.com/NW/1193920087\" target=\"_blank\"><b>汤加火山大爆发：对全球气候、经济有多大影响？</b></a></p><p>奥密克戎扰动全球之际，汤加火山爆发的消息再一次惊动人类社会的敏感神经。南太平洋岛国汤加海域发生大规模火山爆发。火山爆发令汤加互联网连接中断，美国、新西兰、日本、澳大利亚等国家也都发出不同程度的海啸警报。卫星探测结果表明，火山灰最高冲至约28千米高空，卫星云图上甚至可见爆发而上的蘑菇云。</p><p><b>公司新闻</b></p><p><a href=\"https://laohu8.com/NW/1126003111\" target=\"_blank\"><b>美国大型科技公司面临新一轮监管潮！这次影响有多大？</b></a></p><p>欧洲、亚洲和美国正在考虑出台新的法律，以防止大型科技公司利用自身市场力量抑制竞争，此外，新法律可能会涉及限制人脸识别等人工智能技术的使用。</p><p><a href=\"https://laohu8.com/NW/1166061934\" target=\"_blank\"><b>“苹果税”又遭重创！苹果向荷兰&#34;妥协&#34;</b></a></p><p>日前，苹果公司表示，将遵守荷兰消费者与市场监管局的裁决，允许用户在网上苹果商店下载约会软件时，可以使用除苹果系统外的另外两种支付方式。此外，当地时间1月11日，韩国通信委员会表示，苹果公司已经提交了其合规计划，将允许APP开发商在韩国提供第三方支付选项，并降低佣金费用。</p><p><a href=\"https://laohu8.com/NW/2204771743\" target=\"_blank\"><b>瑞士第二大银行瑞士信贷董事长辞职，曾两次违反新冠防疫规定</b></a></p><p>瑞士信贷银行董事长安东尼奥·奥尔塔-奥索里奥17日辞职，原因是违反了新冠疫情隔离规定。据英国广播公司（BBC）17日报道，瑞信开展的内部调查确认，去年7月奥尔塔-奥索里奥在英国观看温布尔顿网球公开赛决赛，而根据当时英国的新冠疫情旅行限制，他本应处于隔离中。此外，他还违反了瑞士的防疫规定。2021年11月28日，他乘飞机抵达瑞士，并于12月1日离境；而根据瑞士防疫规定，他入境后本应隔离10天。</p><p><a href=\"https://laohu8.com/NW/1198581637\" target=\"_blank\"><b>OYO最快本周获上市许可，寻求90亿美元的IPO估值</b></a></p><p>据报道，知情人士今日称，在与潜在投资者进行了初步的接触后，印度经济型连锁酒店OYO计划在IPO（首次公开招股）中寻求约90亿美元的估值。</p><p><a href=\"https://laohu8.com/NW/2204779576\" target=\"_blank\"><b>扩大新冠口服药全球生产版图，辉瑞签下法国CDMO提供原料药</b></a></p><p>法国医药CDMO（研发生产外包服务）公司Novasep宣布已经与辉瑞签订意向书，将加入该公司新冠蛋白酶抑制剂Paxlovid的全球供应链。据悉，这一项目也包含在辉瑞未来五年向法国投资5.2亿欧元的计划中。</p><p><a href=\"https://laohu8.com/NW/1172039194\" target=\"_blank\"><b>联合利华雄心勃勃搞收购，华尔街齐泼冷水</b></a></p><p>在500亿英镑（680亿美元）收购要约遭<a href=\"https://laohu8.com/S/GSK\">葛兰素史克</a>拒绝后，联合利华考虑提高报价。多位分析师对这笔交易持反对态度，称该交易没有意义，估值太高了。</p><p><a href=\"https://laohu8.com/NW/2204776320\" target=\"_blank\"><b>用工荒又来了！麦当劳在美国被迫缩短营业时间</b></a></p><p>麦当劳首席执行官Chris Kempczinski在接受Fox Businesses采访时表示，麦当劳正在限制个别商店的运营时间，以解决因新冠病毒感染人数增加而导致的劳动力短缺问题，一些商店可能会缩减多达10%的营业时间。</p><p><a href=\"https://laohu8.com/NW/2204577650\" target=\"_blank\"><b>美国感染病例激增之际，辉瑞和默沙东新冠口服药物供应正严重短缺</b></a></p><p>辉瑞和默沙东的新冠口服药物被认为是结束这场大流行的关键。然而，在美国Omicron感染病例激增之际，这些新冠口服药物正处于供应严重短缺、生产周期冗长的尴尬境地中。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：大型科技公司面临新一轮监管潮！国际大行董事长辞职</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：大型科技公司面临新一轮监管潮！国际大行董事长辞职\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2022-01-18 06:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><blockquote><b>摘要：</b>因马丁路德金纪念日假期影响，美股周一休市一天；布油触及逾三年新高，美油升破84美元至两个月高位；黄金尝试上破1820美元；苹果被迫放宽支付规定，荷兰监管机构：将审查整改措施；瑞信风波不断！董事长因违反防疫规定下台&gt;&gt;&gt;</blockquote><p><b>国际市场</b></p><p><b>1月17日因马丁·路德·金纪念日，美股休市一天</b></p><p>1月17日（周一）为“马丁·路德·金纪念日”，美股休市一天，1月18日（周二）恢复正常交易。</p><p><b>欧股全线收涨，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数涨0.91%</b></p><p>德国DAX30指数涨0.34%，法国CAC40指数涨0.82%，英国<a href=\"https://laohu8.com/S/.100.UK\">富时100指数</a>涨0.91%，西班牙IBEX35指数涨0.38%，意大利富时MIB指数涨0.5%，欧洲斯托克50指数涨0.74%。</p><p><b>国际原油期货结算价小幅收涨，布油涨0.49%</b></p><p>国际原油期货结算价小幅收涨，布伦特3月原油期货结算价收涨0.42美元，涨幅0.49%，报86.48美元/桶。</p><p><b>金价持稳，投资者在加息前景和Omicron威胁之间进行权衡</b></p><p>黄金价格在创下两个月来最佳单周涨幅后企稳，交易员在货币政策前景和美国新一轮冠状病毒疫情构成的威胁之间进行权衡。黄金价格保持在每盎司1800美元上方，此前金价2021年录得三年来首次下跌，因投资者开始反映货币政策收紧。</p><p><b>国际宏观</b></p><p><a href=\"https://laohu8.com/NW/2204774519\" target=\"_blank\"><b>福奇：尚且无法断言奥密克戎变异株标志着大流行病的结束</b></a></p><p>美国总统首席医学顾问安东尼·福奇博士表示，现在尚且无法断言奥密克戎变异株将标志着新冠疫情从大流行病演变为地方性流行病。“奥密克戎是否会是大家都希望的活病毒疫苗，这是一个悬而未决的问题，因为随着新的变异株的出现，有着很多的可变性，”福奇周一在世界经济论坛的达沃斯议程在线会议上表示。</p><p><a href=\"https://laohu8.com/NW/2204774519\" target=\"_blank\"><b>达利欧警告：通胀恐慌之际，脱离化石燃料不能操之过急</b></a></p><p>对冲基金桥水创始人瑞·达利欧警告称，脱离化石燃料的转型过程不能太快，并表示，通胀飙升之际，停止向该行业供应资金将会产生破坏稳定的效应。</p><p><b>国际劳工组织下调2022年全球劳动力市场复苏预测</b></p><p>总部位于瑞士日内瓦的国际劳工组织发布《世界就业和社会展望2022年趋势》报告。报告显示由于新冠肺炎疫情对全球劳动力市场产生重大影响，2022年全球复苏将缓慢且不确定。</p><p><b>欧元区国家财长会议同意对各国减债计划作出新安排</b></p><p>欧元区19国财政部长当地时间17日在欧盟总部布鲁塞尔举行会议，重点讨论了如何修改欧洲《稳定与增长公约》中关于政府债务上限的条款。欧盟委员会副主席东布罗斯基斯当天会后表示，各国基本同意修改原公约中比较严格的条款，而采取更符合实际也更可操作的办法。</p><p><b>17日美国东部超过5000万人收到冬季风暴警报</b></p><p>据美国有线电视新闻网（CNN）当地时间1月17日报道，冬季风暴持续侵袭美国东部，17日早间已经有超过5000万人收到风暴相关的极端天气警报。风暴带来的龙卷风、冻雨和大雪也席卷了从佛罗里达州到缅因州的部分地区。受风暴影响，航班取消和各地断电的问题也依旧严峻。</p><p><a href=\"https://laohu8.com/NW/1193920087\" target=\"_blank\"><b>汤加火山大爆发：对全球气候、经济有多大影响？</b></a></p><p>奥密克戎扰动全球之际，汤加火山爆发的消息再一次惊动人类社会的敏感神经。南太平洋岛国汤加海域发生大规模火山爆发。火山爆发令汤加互联网连接中断，美国、新西兰、日本、澳大利亚等国家也都发出不同程度的海啸警报。卫星探测结果表明，火山灰最高冲至约28千米高空，卫星云图上甚至可见爆发而上的蘑菇云。</p><p><b>公司新闻</b></p><p><a href=\"https://laohu8.com/NW/1126003111\" target=\"_blank\"><b>美国大型科技公司面临新一轮监管潮！这次影响有多大？</b></a></p><p>欧洲、亚洲和美国正在考虑出台新的法律，以防止大型科技公司利用自身市场力量抑制竞争，此外，新法律可能会涉及限制人脸识别等人工智能技术的使用。</p><p><a href=\"https://laohu8.com/NW/1166061934\" target=\"_blank\"><b>“苹果税”又遭重创！苹果向荷兰&#34;妥协&#34;</b></a></p><p>日前，苹果公司表示，将遵守荷兰消费者与市场监管局的裁决，允许用户在网上苹果商店下载约会软件时，可以使用除苹果系统外的另外两种支付方式。此外，当地时间1月11日，韩国通信委员会表示，苹果公司已经提交了其合规计划，将允许APP开发商在韩国提供第三方支付选项，并降低佣金费用。</p><p><a href=\"https://laohu8.com/NW/2204771743\" target=\"_blank\"><b>瑞士第二大银行瑞士信贷董事长辞职，曾两次违反新冠防疫规定</b></a></p><p>瑞士信贷银行董事长安东尼奥·奥尔塔-奥索里奥17日辞职，原因是违反了新冠疫情隔离规定。据英国广播公司（BBC）17日报道，瑞信开展的内部调查确认，去年7月奥尔塔-奥索里奥在英国观看温布尔顿网球公开赛决赛，而根据当时英国的新冠疫情旅行限制，他本应处于隔离中。此外，他还违反了瑞士的防疫规定。2021年11月28日，他乘飞机抵达瑞士，并于12月1日离境；而根据瑞士防疫规定，他入境后本应隔离10天。</p><p><a href=\"https://laohu8.com/NW/1198581637\" target=\"_blank\"><b>OYO最快本周获上市许可，寻求90亿美元的IPO估值</b></a></p><p>据报道，知情人士今日称，在与潜在投资者进行了初步的接触后，印度经济型连锁酒店OYO计划在IPO（首次公开招股）中寻求约90亿美元的估值。</p><p><a href=\"https://laohu8.com/NW/2204779576\" target=\"_blank\"><b>扩大新冠口服药全球生产版图，辉瑞签下法国CDMO提供原料药</b></a></p><p>法国医药CDMO（研发生产外包服务）公司Novasep宣布已经与辉瑞签订意向书，将加入该公司新冠蛋白酶抑制剂Paxlovid的全球供应链。据悉，这一项目也包含在辉瑞未来五年向法国投资5.2亿欧元的计划中。</p><p><a href=\"https://laohu8.com/NW/1172039194\" target=\"_blank\"><b>联合利华雄心勃勃搞收购，华尔街齐泼冷水</b></a></p><p>在500亿英镑（680亿美元）收购要约遭<a href=\"https://laohu8.com/S/GSK\">葛兰素史克</a>拒绝后，联合利华考虑提高报价。多位分析师对这笔交易持反对态度，称该交易没有意义，估值太高了。</p><p><a href=\"https://laohu8.com/NW/2204776320\" target=\"_blank\"><b>用工荒又来了！麦当劳在美国被迫缩短营业时间</b></a></p><p>麦当劳首席执行官Chris Kempczinski在接受Fox Businesses采访时表示，麦当劳正在限制个别商店的运营时间，以解决因新冠病毒感染人数增加而导致的劳动力短缺问题，一些商店可能会缩减多达10%的营业时间。</p><p><a href=\"https://laohu8.com/NW/2204577650\" target=\"_blank\"><b>美国感染病例激增之际，辉瑞和默沙东新冠口服药物供应正严重短缺</b></a></p><p>辉瑞和默沙东的新冠口服药物被认为是结束这场大流行的关键。然而，在美国Omicron感染病例激增之际，这些新冠口服药物正处于供应严重短缺、生产周期冗长的尴尬境地中。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133140064","content_text":"摘要：因马丁路德金纪念日假期影响，美股周一休市一天；布油触及逾三年新高，美油升破84美元至两个月高位；黄金尝试上破1820美元；苹果被迫放宽支付规定，荷兰监管机构：将审查整改措施；瑞信风波不断！董事长因违反防疫规定下台>>>国际市场1月17日因马丁·路德·金纪念日，美股休市一天1月17日（周一）为“马丁·路德·金纪念日”，美股休市一天，1月18日（周二）恢复正常交易。欧股全线收涨，英国富时100指数涨0.91%德国DAX30指数涨0.34%，法国CAC40指数涨0.82%，英国富时100指数涨0.91%，西班牙IBEX35指数涨0.38%，意大利富时MIB指数涨0.5%，欧洲斯托克50指数涨0.74%。国际原油期货结算价小幅收涨，布油涨0.49%国际原油期货结算价小幅收涨，布伦特3月原油期货结算价收涨0.42美元，涨幅0.49%，报86.48美元/桶。金价持稳，投资者在加息前景和Omicron威胁之间进行权衡黄金价格在创下两个月来最佳单周涨幅后企稳，交易员在货币政策前景和美国新一轮冠状病毒疫情构成的威胁之间进行权衡。黄金价格保持在每盎司1800美元上方，此前金价2021年录得三年来首次下跌，因投资者开始反映货币政策收紧。国际宏观福奇：尚且无法断言奥密克戎变异株标志着大流行病的结束美国总统首席医学顾问安东尼·福奇博士表示，现在尚且无法断言奥密克戎变异株将标志着新冠疫情从大流行病演变为地方性流行病。“奥密克戎是否会是大家都希望的活病毒疫苗，这是一个悬而未决的问题，因为随着新的变异株的出现，有着很多的可变性，”福奇周一在世界经济论坛的达沃斯议程在线会议上表示。达利欧警告：通胀恐慌之际，脱离化石燃料不能操之过急对冲基金桥水创始人瑞·达利欧警告称，脱离化石燃料的转型过程不能太快，并表示，通胀飙升之际，停止向该行业供应资金将会产生破坏稳定的效应。国际劳工组织下调2022年全球劳动力市场复苏预测总部位于瑞士日内瓦的国际劳工组织发布《世界就业和社会展望2022年趋势》报告。报告显示由于新冠肺炎疫情对全球劳动力市场产生重大影响，2022年全球复苏将缓慢且不确定。欧元区国家财长会议同意对各国减债计划作出新安排欧元区19国财政部长当地时间17日在欧盟总部布鲁塞尔举行会议，重点讨论了如何修改欧洲《稳定与增长公约》中关于政府债务上限的条款。欧盟委员会副主席东布罗斯基斯当天会后表示，各国基本同意修改原公约中比较严格的条款，而采取更符合实际也更可操作的办法。17日美国东部超过5000万人收到冬季风暴警报据美国有线电视新闻网（CNN）当地时间1月17日报道，冬季风暴持续侵袭美国东部，17日早间已经有超过5000万人收到风暴相关的极端天气警报。风暴带来的龙卷风、冻雨和大雪也席卷了从佛罗里达州到缅因州的部分地区。受风暴影响，航班取消和各地断电的问题也依旧严峻。汤加火山大爆发：对全球气候、经济有多大影响？奥密克戎扰动全球之际，汤加火山爆发的消息再一次惊动人类社会的敏感神经。南太平洋岛国汤加海域发生大规模火山爆发。火山爆发令汤加互联网连接中断，美国、新西兰、日本、澳大利亚等国家也都发出不同程度的海啸警报。卫星探测结果表明，火山灰最高冲至约28千米高空，卫星云图上甚至可见爆发而上的蘑菇云。公司新闻美国大型科技公司面临新一轮监管潮！这次影响有多大？欧洲、亚洲和美国正在考虑出台新的法律，以防止大型科技公司利用自身市场力量抑制竞争，此外，新法律可能会涉及限制人脸识别等人工智能技术的使用。“苹果税”又遭重创！苹果向荷兰\"妥协\"日前，苹果公司表示，将遵守荷兰消费者与市场监管局的裁决，允许用户在网上苹果商店下载约会软件时，可以使用除苹果系统外的另外两种支付方式。此外，当地时间1月11日，韩国通信委员会表示，苹果公司已经提交了其合规计划，将允许APP开发商在韩国提供第三方支付选项，并降低佣金费用。瑞士第二大银行瑞士信贷董事长辞职，曾两次违反新冠防疫规定瑞士信贷银行董事长安东尼奥·奥尔塔-奥索里奥17日辞职，原因是违反了新冠疫情隔离规定。据英国广播公司（BBC）17日报道，瑞信开展的内部调查确认，去年7月奥尔塔-奥索里奥在英国观看温布尔顿网球公开赛决赛，而根据当时英国的新冠疫情旅行限制，他本应处于隔离中。此外，他还违反了瑞士的防疫规定。2021年11月28日，他乘飞机抵达瑞士，并于12月1日离境；而根据瑞士防疫规定，他入境后本应隔离10天。OYO最快本周获上市许可，寻求90亿美元的IPO估值据报道，知情人士今日称，在与潜在投资者进行了初步的接触后，印度经济型连锁酒店OYO计划在IPO（首次公开招股）中寻求约90亿美元的估值。扩大新冠口服药全球生产版图，辉瑞签下法国CDMO提供原料药法国医药CDMO（研发生产外包服务）公司Novasep宣布已经与辉瑞签订意向书，将加入该公司新冠蛋白酶抑制剂Paxlovid的全球供应链。据悉，这一项目也包含在辉瑞未来五年向法国投资5.2亿欧元的计划中。联合利华雄心勃勃搞收购，华尔街齐泼冷水在500亿英镑（680亿美元）收购要约遭葛兰素史克拒绝后，联合利华考虑提高报价。多位分析师对这笔交易持反对态度，称该交易没有意义，估值太高了。用工荒又来了！麦当劳在美国被迫缩短营业时间麦当劳首席执行官Chris Kempczinski在接受Fox Businesses采访时表示，麦当劳正在限制个别商店的运营时间，以解决因新冠病毒感染人数增加而导致的劳动力短缺问题，一些商店可能会缩减多达10%的营业时间。美国感染病例激增之际，辉瑞和默沙东新冠口服药物供应正严重短缺辉瑞和默沙东的新冠口服药物被认为是结束这场大流行的关键。然而，在美国Omicron感染病例激增之际，这些新冠口服药物正处于供应严重短缺、生产周期冗长的尴尬境地中。","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":3109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694356383,"gmtCreate":1641827250954,"gmtModify":1641827251130,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694356383","repostId":"1130016333","repostType":4,"repost":{"id":"1130016333","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641826618,"share":"https://www.laohu8.com/m/news/1130016333?lang=zh_CN&edition=full","pubTime":"2022-01-10 22:56","market":"us","language":"en","title":"Semiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1130016333","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading. Nvidia, AMD, ASML, Qualcomm, STMicroelectronics fell","content":"<p><html><head></head><body>Semiconductor stocks dipped in morning trading. Nvidia, <a href=\"https://laohu8.com/S/AMD\">AMD</a>, ASML, <a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>, STMicroelectronics fell between 1% and 6%.</p><p><blockquote><html><head></head><body>半导体股早盘下跌。英伟达，<a href=\"https://laohu8.com/S/AMD\">AMD</a>,阿斯麦,<a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>、意法半导体跌幅在1%-6%之间。</body></html></blockquote></p><p><img src=\"https://static.tigerbbs.com/7194f4d04dede76c6c5e8c137084e2af\" tg-width=\"1021\" tg-height=\"635\" referrerpolicy=\"no-referrer\"/></p><p><blockquote></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-10 22:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Semiconductor stocks dipped in morning trading. Nvidia, <a href=\"https://laohu8.com/S/AMD\">AMD</a>, ASML, <a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>, STMicroelectronics fell between 1% and 6%.</p><p><blockquote><html><head></head><body>半导体股早盘下跌。英伟达，<a href=\"https://laohu8.com/S/AMD\">AMD</a>,阿斯麦,<a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>、意法半导体跌幅在1%-6%之间。</body></html></blockquote></p><p><img src=\"https://static.tigerbbs.com/7194f4d04dede76c6c5e8c137084e2af\" tg-width=\"1021\" tg-height=\"635\" referrerpolicy=\"no-referrer\"/></p><p><blockquote></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4534":"瑞士信贷持仓","BK4141":"半导体产品","BK4554":"元宇宙及AR概念","AMD":"美国超微公司","BK4532":"文艺复兴科技持仓","NVDA":"英伟达","BK4515":"5G概念","BK4529":"IDC概念","BK4512":"苹果概念","BK4527":"明星科技股","BK4566":"资本集团","QCOM":"高通"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130016333","content_text":"Semiconductor stocks dipped in morning trading. Nvidia, AMD, ASML, Qualcomm, STMicroelectronics fell between 1% and 6%.","news_type":1,"symbols_score_info":{"QCOM":0.9,"AMD":0.9,"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":3020,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699318218,"gmtCreate":1639748546241,"gmtModify":1639748546363,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Waiting to buy","listText":"Waiting to buy","text":"Waiting to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699318218","repostId":"607922432","repostType":1,"repost":{"id":607922432,"gmtCreate":1639477553823,"gmtModify":1639532189391,"author":{"id":"9000000000000104","authorId":"9000000000000104","name":"小左第一视角","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000104","authorIdStr":"9000000000000104"},"themes":[],"title":"","htmlText":"\n \n \n  美股会走空吗？TSLA又下跌了！科技龙头洗盘加深了。PFE、BNTX、AAPL、TSLA、NVDA、AMZN、MSFT、EPAM、FB、KO、LCID、MRK、NIO、ROKU、TSLA小左1213一\n \n","listText":"美股会走空吗？TSLA又下跌了！科技龙头洗盘加深了。PFE、BNTX、AAPL、TSLA、NVDA、AMZN、MSFT、EPAM、FB、KO、LCID、MRK、NIO、ROKU、TSLA小左1213一","text":"美股会走空吗？TSLA又下跌了！科技龙头洗盘加深了。PFE、BNTX、AAPL、TSLA、NVDA、AMZN、MSFT、EPAM、FB、KO、LCID、MRK、NIO、ROKU、TSLA小左1213一","images":[],"top":1,"highlighted":2,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607922432","isVote":1,"tweetType":2,"object":{"id":"8c3d4fe6198f420fb76259b52473879c","tweetId":"607922432","title":"美股会走空吗？TSLA又下跌了！科技龙头洗盘加深了。PFE、BNTX、AAPL、TSLA、NVDA、AMZN、MSFT、EPAM、FB、KO、LCID、MRK、NIO、ROKU、TSLA小左1213一","videoUrl":"http://v.tigerbbs.com/16394775479509ce166bef45a7fbd18203a7a172dd96f.mp4","poster":"https://static.tigerbbs.com/9e76831e82c75663da8db2e33938cf07","shareLink":"http://v.tigerbbs.com/16394775479509ce166bef45a7fbd18203a7a172dd96f.mp4"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605276319,"gmtCreate":1639185690213,"gmtModify":1639185690372,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Not good","listText":"Not good","text":"Not good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605276319","repostId":"1133027099","repostType":2,"repost":{"id":"1133027099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639152670,"share":"https://www.laohu8.com/m/news/1133027099?lang=zh_CN&edition=full","pubTime":"2021-12-11 00:11","market":"us","language":"en","title":"Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133027099","media":"Tiger Newspress","summary":"Sea Ltd stock dropped more than 5% in morning trading.","content":"<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-11 00:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133027099","content_text":"Sea Ltd stock dropped more than 5% in morning trading.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":4567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605986032,"gmtCreate":1639101650841,"gmtModify":1639101650982,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good.. Buy tsm","listText":"Good.. Buy tsm","text":"Good.. Buy tsm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605986032","repostId":"2190643897","repostType":4,"isVote":1,"tweetType":1,"viewCount":902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605988892,"gmtCreate":1639101616431,"gmtModify":1639101616581,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Buy more tsla","listText":"Buy more tsla","text":"Buy more tsla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605988892","repostId":"2190641206","repostType":4,"isVote":1,"tweetType":1,"viewCount":942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605989890,"gmtCreate":1639101433305,"gmtModify":1639101433450,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605989890","repostId":"1123707804","repostType":4,"repost":{"id":"1123707804","kind":"news","pubTimestamp":1639098283,"share":"https://www.laohu8.com/m/news/1123707804?lang=zh_CN&edition=full","pubTime":"2021-12-10 09:04","market":"us","language":"en","title":"Cathie Wood Says Ark ‘Soul-Searching’ as Once-Stellar Funds Lag<blockquote>凯西·伍德(Cathie Wood)表示，方舟正在“反省”，因为曾经的明星基金落后了</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1123707804","media":"Bloomberg","summary":"(Bloomberg) -- Ark Investment Management is “going through soul-searching” as its growth-focused fun","content":"<p>(Bloomberg) -- Ark Investment Management is “going through soul-searching” as its growth-focused funds fall out of favor amid expectations of tighter Federal Reserve policy, said founder Cathie Wood.</p><p><blockquote>（彭博社）——方舟投资管理公司创始人凯西·伍德表示，由于美联储收紧政策的预期，其专注于增长的基金失宠，方舟投资管理公司正在“进行自我反省”。</blockquote></p><p> The $17.8 billion ARK Innovation ETF has tumbled more than 20% this year, with several of its top holdings like electric-vehicle giant Tesla Inc. and video-streaming platform Roku Inc. down from their peaks. During the same period, the S&amp;P 500 Index climbed about 24%.</p><p><blockquote>价值178亿美元的ARK Innovation ETF今年已下跌超过20%，其中电动汽车巨头特斯拉公司和视频流媒体平台Roku公司等几家顶级持股均从峰值回落。同期，标普500指数攀升约24%。</blockquote></p><p> “I’ve never been in a market that is up -- has appreciated -- and our strategies are down,” Wood said in a Thursday interview with Bloomberg Television. “That has never happened before.”</p><p><blockquote>伍德周四在接受彭博电视台采访时表示：“我从未经历过上涨、升值而我们的策略却下跌的市场。”“这在以前从未发生过。”</blockquote></p><p> Wood says her funds are sticking to their plans even after the rough stretch, and that their models forecast big returns in the next half decade.</p><p><blockquote>伍德表示，即使在经历了艰难时期后，她的基金仍坚持他们的计划，他们的模型预测未来五年将获得巨大回报。</blockquote></p><p> “Our strategy is our strategy,” she said. “The opportunity in our strategy is huge right now. We expect a compound annual rate of return of roughly over 40% over the next five years.”</p><p><blockquote>“我们的策略就是我们的策略，”她说。“目前我们战略中的机会是巨大的。我们预计未来五年的复合年回报率约为40%以上。”</blockquote></p><p> “When we go through a period like this, of course we are going through soul-searching, saying ‘are we missing something?’” she said, adding that in response, Ark has doubled down on its research and modeling.</p><p><blockquote>“当我们经历这样的时期时，我们当然会进行自我反省，问‘我们是否遗漏了什么？’”她说，并补充说，作为回应，Ark加倍了研究和建模。</blockquote></p><p> Wood noted that the companies she invests in are aggressively investing in the future. While those stocks may have high multiples now, Ark is assuming that those valuations are going to compress in the longer term.</p><p><blockquote>伍德指出，她投资的公司正在积极投资未来。虽然这些股票现在的市盈率可能很高，但Ark假设这些估值从长远来看将会压缩。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Says Ark ‘Soul-Searching’ as Once-Stellar Funds Lag<blockquote>凯西·伍德(Cathie Wood)表示，方舟正在“反省”，因为曾经的明星基金落后了</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Says Ark ‘Soul-Searching’ as Once-Stellar Funds Lag<blockquote>凯西·伍德(Cathie Wood)表示，方舟正在“反省”，因为曾经的明星基金落后了</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-10 09:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Ark Investment Management is “going through soul-searching” as its growth-focused funds fall out of favor amid expectations of tighter Federal Reserve policy, said founder Cathie Wood.</p><p><blockquote>（彭博社）——方舟投资管理公司创始人凯西·伍德表示，由于美联储收紧政策的预期，其专注于增长的基金失宠，方舟投资管理公司正在“进行自我反省”。</blockquote></p><p> The $17.8 billion ARK Innovation ETF has tumbled more than 20% this year, with several of its top holdings like electric-vehicle giant Tesla Inc. and video-streaming platform Roku Inc. down from their peaks. During the same period, the S&amp;P 500 Index climbed about 24%.</p><p><blockquote>价值178亿美元的ARK Innovation ETF今年已下跌超过20%，其中电动汽车巨头特斯拉公司和视频流媒体平台Roku公司等几家顶级持股均从峰值回落。同期，标普500指数攀升约24%。</blockquote></p><p> “I’ve never been in a market that is up -- has appreciated -- and our strategies are down,” Wood said in a Thursday interview with Bloomberg Television. “That has never happened before.”</p><p><blockquote>伍德周四在接受彭博电视台采访时表示：“我从未经历过上涨、升值而我们的策略却下跌的市场。”“这在以前从未发生过。”</blockquote></p><p> Wood says her funds are sticking to their plans even after the rough stretch, and that their models forecast big returns in the next half decade.</p><p><blockquote>伍德表示，即使在经历了艰难时期后，她的基金仍坚持他们的计划，他们的模型预测未来五年将获得巨大回报。</blockquote></p><p> “Our strategy is our strategy,” she said. “The opportunity in our strategy is huge right now. We expect a compound annual rate of return of roughly over 40% over the next five years.”</p><p><blockquote>“我们的策略就是我们的策略，”她说。“目前我们战略中的机会是巨大的。我们预计未来五年的复合年回报率约为40%以上。”</blockquote></p><p> “When we go through a period like this, of course we are going through soul-searching, saying ‘are we missing something?’” she said, adding that in response, Ark has doubled down on its research and modeling.</p><p><blockquote>“当我们经历这样的时期时，我们当然会进行自我反省，问‘我们是否遗漏了什么？’”她说，并补充说，作为回应，Ark加倍了研究和建模。</blockquote></p><p> Wood noted that the companies she invests in are aggressively investing in the future. While those stocks may have high multiples now, Ark is assuming that those valuations are going to compress in the longer term.</p><p><blockquote>伍德指出，她投资的公司正在积极投资未来。虽然这些股票现在的市盈率可能很高，但Ark假设这些估值从长远来看将会压缩。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/cathie-wood-says-ark-soul-205200351.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF"},"source_url":"https://finance.yahoo.com/news/cathie-wood-says-ark-soul-205200351.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123707804","content_text":"(Bloomberg) -- Ark Investment Management is “going through soul-searching” as its growth-focused funds fall out of favor amid expectations of tighter Federal Reserve policy, said founder Cathie Wood.\nThe $17.8 billion ARK Innovation ETF has tumbled more than 20% this year, with several of its top holdings like electric-vehicle giant Tesla Inc. and video-streaming platform Roku Inc. down from their peaks. During the same period, the S&P 500 Index climbed about 24%.\n“I’ve never been in a market that is up -- has appreciated -- and our strategies are down,” Wood said in a Thursday interview with Bloomberg Television. “That has never happened before.”\nWood says her funds are sticking to their plans even after the rough stretch, and that their models forecast big returns in the next half decade.\n“Our strategy is our strategy,” she said. “The opportunity in our strategy is huge right now. We expect a compound annual rate of return of roughly over 40% over the next five years.”\n“When we go through a period like this, of course we are going through soul-searching, saying ‘are we missing something?’” she said, adding that in response, Ark has doubled down on its research and modeling.\nWood noted that the companies she invests in are aggressively investing in the future. While those stocks may have high multiples now, Ark is assuming that those valuations are going to compress in the longer term.","news_type":1,"symbols_score_info":{"ARKK":0.9}},"isVote":1,"tweetType":1,"viewCount":1211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605980043,"gmtCreate":1639101321359,"gmtModify":1639101321493,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605980043","repostId":"1196531742","repostType":4,"repost":{"id":"1196531742","kind":"news","pubTimestamp":1639100306,"share":"https://www.laohu8.com/m/news/1196531742?lang=zh_CN&edition=full","pubTime":"2021-12-10 09:38","market":"us","language":"en","title":"Do People Really Consult Horoscopes For Buying Stocks? You Might Be Surprised!<blockquote>人们买股票真的会看八字吗？你可能会感到惊讶！</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196531742","media":"benzinga","summary":"When making decisions related to the stock market, it seems that nearly one in five Americans are by","content":"<p><div> When making decisions related to the stock market, it seems that nearly one in five Americans are bypassing the sage advice of Money Mitch and Spencer Israel in favor of the astrological insights of ...</p><p><blockquote><div>在做出与股市相关的决定时，似乎有近五分之一的美国人绕过了金钱米奇和斯潘塞·伊斯雷尔的明智建议，转而支持占星术的见解...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/12/24530267/do-people-really-consult-horoscopes-for-buying-stocks-you-might-be-surprised\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/12/24530267/do-people-really-consult-horoscopes-for-buying-stocks-you-might-be-surprised\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Do People Really Consult Horoscopes For Buying Stocks? You Might Be Surprised!<blockquote>人们买股票真的会看八字吗？你可能会感到惊讶！</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDo People Really Consult Horoscopes For Buying Stocks? You Might Be Surprised!<blockquote>人们买股票真的会看八字吗？你可能会感到惊讶！</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">benzinga</strong><span class=\"h-time small\">2021-12-10 09:38</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> When making decisions related to the stock market, it seems that nearly one in five Americans are bypassing the sage advice of Money Mitch and Spencer Israel in favor of the astrological insights of ...</p><p><blockquote><div>在做出与股市相关的决定时，似乎有近五分之一的美国人绕过了金钱米奇和斯潘塞·伊斯雷尔的明智建议，转而支持占星术的见解...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/12/24530267/do-people-really-consult-horoscopes-for-buying-stocks-you-might-be-surprised\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/12/24530267/do-people-really-consult-horoscopes-for-buying-stocks-you-might-be-surprised\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/12/24530267/do-people-really-consult-horoscopes-for-buying-stocks-you-might-be-surprised\">benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TREE":"LendingTree"},"source_url":"https://www.benzinga.com/news/21/12/24530267/do-people-really-consult-horoscopes-for-buying-stocks-you-might-be-surprised","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196531742","content_text":"When making decisions related to the stock market, it seems that nearly one in five Americans are bypassing the sage advice of Money Mitch and Spencer Israel in favor of the astrological insights of Chani Nicholas and Jessica Lanyadoo.\n\nWhen The Moon Is In the Seventh House: The majority of Americans (63.4%) follow astrology and 19.2% have made a financial decision based on their horoscope, according to a new study released by LendingTree TREE -4.14% . Millennials are more likely to seek astrological advice (30.1%) versus Gen Zers (24.1%), Gen Xers (18.1%) and baby boomers (3.7%), while more women follow astrology than men (78.2% versus 47.6%, respectively).\n\nAmericans mostly tap into their horoscope for making decisions on how to save money (42.1%) and whether it makes sense to splurge rather than save (33.5%). But 23.1% rely on astrology for buying or selling stocks, and then same percentage align their job-seeking activities with the positioning of the stars and the planets.\n\n\n\nAnd Jupiter Aligns With Mars: Among the zodiac signs, the highest astrological signs for credit score averages are Taurus (713.6) and Gemini (713), with Sagittarius carrying the lowest average at 708.7. Geminis are more comfortable with risky investments than other signs while Aries tend to be more conservative than other signs.\n\nHowever, LendingTree cautions that there are more reliable methods for investing, saving and other money-related activities.\n\n“Horoscopes are fun and interesting, but it seems really unwise to make any significant financial decision based on them,” said Matt Schulz, LendingTree chief credit analyst. “You are far better off consulting with a financial adviser, meeting with a credit counselor, reading one of the myriad books available from personal finance experts or just speaking with a financially savvy relative or colleague instead.”\n\nLendingTree compiled its data from Nov. 3-5 through a poll of 394 American adults who used their horoscope to make a financial decision.","news_type":1,"symbols_score_info":{"TREE":0.9}},"isVote":1,"tweetType":1,"viewCount":1360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602695508,"gmtCreate":1639012343802,"gmtModify":1639012343907,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602695508","repostId":"1137331022","repostType":2,"repost":{"id":"1137331022","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639005672,"share":"https://www.laohu8.com/m/news/1137331022?lang=zh_CN&edition=full","pubTime":"2021-12-09 07:21","market":"sh","language":"zh","title":"昨夜今晨：疫苗利好再度传来！苹果续刷历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1137331022","media":"老虎资讯综合","summary":"摘要：美股三大指数小幅收涨，苹果续创历史新高；中概股多数上涨，雾芯科技收涨超21%；辉瑞公司宣布加强针疫苗可中和奥密克戎毒株；游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%>>>\n\n海外市场\n美股三大指","content":"<blockquote>\n <b>摘要：</b>美股三大指数小幅收涨，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>续创历史新高；中概股多数上涨，雾芯科技收涨超21%；<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>公司宣布加强针疫苗可中和奥密克戎毒株；<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>Q3净亏损同比扩大，盘后一度跌逾7%&gt;&gt;&gt;\n</blockquote>\n<p><b>海外市场</b></p>\n<p><b>美股三大指数小幅收涨，苹果续创收盘历史新高</b></p>\n<p>美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。</p>\n<p><b>热门中概股收盘大多走高，雾芯科技涨超21%</b></p>\n<p>中概股多数上涨，雾芯科技收涨超21%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>涨超13%，<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>涨超11%，<a href=\"https://laohu8.com/S/GOTU\">高途</a>涨超11%，<a href=\"https://laohu8.com/S/LUCKIN\">瑞幸咖啡</a>涨超9%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>涨超8%，<a href=\"https://laohu8.com/S/ZTO\">中通快递</a>涨近6%；中概新能源汽车中，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超5.8%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>涨2.1%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超1%。</p>\n<p><b>美油收高0.4%，布油上涨0.5%</b></p>\n<p>美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲<a href=\"https://laohu8.com/S/ICE\">洲际交易所</a>2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。</p>\n<p><b>黄金期货收高0.1%，并创一周来盘中最高价</b></p>\n<p>黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。</p>\n<p><b>欧股主要指数收跌，德国DAX30指数跌0.79%</b></p>\n<p>德国DAX30指数周三收跌0.79%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></a></p>\n<p>辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>摩根大通：2022年全球经济将全面复苏</b></a></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p><b>世卫组织：奥密克戎毒株将显著影响全球疫情</b></p>\n<p>世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。</p>\n<p><a href=\"https://laohu8.com/NW/2190693181\" target=\"_blank\"><b>全球芯片短缺问题未有起色，交付等待时长再创历史新高</b></a></p>\n<p>芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。</p>\n<p><a href=\"https://laohu8.com/NW/2190869550\" target=\"_blank\"><b>美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓</b></a><b></b></p>\n<p>美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>英国首相恢复居家工作建议 以遏制omicron传播</b></a></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p><b>公司新闻</b></p>\n<p><a href=\"https://laohu8.com/NW/2190931896\" target=\"_blank\"><b>苹果股价续刷历史新高，市值逼近3万亿美元</b></a></p>\n<p>周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。</p>\n<p><a href=\"https://laohu8.com/NW/1141082394\" target=\"_blank\"><b>飙涨近22%！电子烟龙头豪掷超30亿回购股票</b></a></p>\n<p>电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。</p>\n<p><a href=\"https://laohu8.com/NW/1124189543\" target=\"_blank\"><b>辉瑞：加强针疫苗可中和奥密克戎毒株</b></a></p>\n<p>辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。</p>\n<p><b><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>Evusheld疫苗获得美国食品药品监督管理局紧急使用授权</b></p>\n<p>周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。</p>\n<p><a href=\"https://laohu8.com/NW/2189667417\" target=\"_blank\"><b>谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行</b></a></p>\n<p>据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”</p>\n<p><a href=\"https://laohu8.com/NW/2189663059\" target=\"_blank\"><b>福特首款电动皮卡需求火爆，预订量接近20万辆</b></a></p>\n<p>据报道，<a href=\"https://laohu8.com/S/F\">福特汽车</a>证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。</p>\n<p><a href=\"https://laohu8.com/NW/2189527726\" target=\"_blank\"><b>英特尔CEO：供应链问题将持续至2023年</b></a></p>\n<p>英特尔和<a href=\"https://laohu8.com/S/ACN\">埃森哲</a>CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”</p>\n<p><a href=\"https://laohu8.com/NW/1131202578\" target=\"_blank\"><b>游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%</b></a></p>\n<p>财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。</p>\n<p><a href=\"https://laohu8.com/NW/1177663836\" target=\"_blank\"><b>UiPath&nbsp;2022财年第三季度净亏损同比扩大</b></a></p>\n<p>财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：疫苗利好再度传来！苹果续刷历史新高</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：疫苗利好再度传来！苹果续刷历史新高\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-09 07:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n <b>摘要：</b>美股三大指数小幅收涨，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>续创历史新高；中概股多数上涨，雾芯科技收涨超21%；<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>公司宣布加强针疫苗可中和奥密克戎毒株；<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>Q3净亏损同比扩大，盘后一度跌逾7%&gt;&gt;&gt;\n</blockquote>\n<p><b>海外市场</b></p>\n<p><b>美股三大指数小幅收涨，苹果续创收盘历史新高</b></p>\n<p>美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。</p>\n<p><b>热门中概股收盘大多走高，雾芯科技涨超21%</b></p>\n<p>中概股多数上涨，雾芯科技收涨超21%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>涨超13%，<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>涨超11%，<a href=\"https://laohu8.com/S/GOTU\">高途</a>涨超11%，<a href=\"https://laohu8.com/S/LUCKIN\">瑞幸咖啡</a>涨超9%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>涨超8%，<a href=\"https://laohu8.com/S/ZTO\">中通快递</a>涨近6%；中概新能源汽车中，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>涨超5.8%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>涨2.1%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>涨超1%。</p>\n<p><b>美油收高0.4%，布油上涨0.5%</b></p>\n<p>美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲<a href=\"https://laohu8.com/S/ICE\">洲际交易所</a>2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。</p>\n<p><b>黄金期货收高0.1%，并创一周来盘中最高价</b></p>\n<p>黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。</p>\n<p><b>欧股主要指数收跌，德国DAX30指数跌0.79%</b></p>\n<p>德国DAX30指数周三收跌0.79%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></a></p>\n<p>辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>摩根大通：2022年全球经济将全面复苏</b></a></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p><b>世卫组织：奥密克戎毒株将显著影响全球疫情</b></p>\n<p>世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。</p>\n<p><a href=\"https://laohu8.com/NW/2190693181\" target=\"_blank\"><b>全球芯片短缺问题未有起色，交付等待时长再创历史新高</b></a></p>\n<p>芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。</p>\n<p><a href=\"https://laohu8.com/NW/2190869550\" target=\"_blank\"><b>美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓</b></a><b></b></p>\n<p>美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2190969538\" target=\"_blank\"><b>英国首相恢复居家工作建议 以遏制omicron传播</b></a></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p><b>公司新闻</b></p>\n<p><a href=\"https://laohu8.com/NW/2190931896\" target=\"_blank\"><b>苹果股价续刷历史新高，市值逼近3万亿美元</b></a></p>\n<p>周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。</p>\n<p><a href=\"https://laohu8.com/NW/1141082394\" target=\"_blank\"><b>飙涨近22%！电子烟龙头豪掷超30亿回购股票</b></a></p>\n<p>电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。</p>\n<p><a href=\"https://laohu8.com/NW/1124189543\" target=\"_blank\"><b>辉瑞：加强针疫苗可中和奥密克戎毒株</b></a></p>\n<p>辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。</p>\n<p><b><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>Evusheld疫苗获得美国食品药品监督管理局紧急使用授权</b></p>\n<p>周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。</p>\n<p><a href=\"https://laohu8.com/NW/2189667417\" target=\"_blank\"><b>谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行</b></a></p>\n<p>据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”</p>\n<p><a href=\"https://laohu8.com/NW/2189663059\" target=\"_blank\"><b>福特首款电动皮卡需求火爆，预订量接近20万辆</b></a></p>\n<p>据报道，<a href=\"https://laohu8.com/S/F\">福特汽车</a>证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。</p>\n<p><a href=\"https://laohu8.com/NW/2189527726\" target=\"_blank\"><b>英特尔CEO：供应链问题将持续至2023年</b></a></p>\n<p>英特尔和<a href=\"https://laohu8.com/S/ACN\">埃森哲</a>CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”</p>\n<p><a href=\"https://laohu8.com/NW/1131202578\" target=\"_blank\"><b>游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%</b></a></p>\n<p>财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。</p>\n<p><a href=\"https://laohu8.com/NW/1177663836\" target=\"_blank\"><b>UiPath&nbsp;2022财年第三季度净亏损同比扩大</b></a></p>\n<p>财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{".SPX":"S&P 500 Index","BK4566":"资本集团","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","BK4505":"高瓴资本持仓","BK4507":"流媒体概念","AAPL":"苹果","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4170":"电脑硬件、储存设备及电脑周边","BK4515":"5G概念","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)",".DJI":"道琼斯","BK4559":"巴菲特持仓","BK4501":"段永平概念",".IXIC":"NASDAQ Composite","BK4553":"喜马拉雅资本持仓"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137331022","content_text":"摘要：美股三大指数小幅收涨，苹果续创历史新高；中概股多数上涨，雾芯科技收涨超21%；辉瑞公司宣布加强针疫苗可中和奥密克戎毒株；游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%>>>\n\n海外市场\n美股三大指数小幅收涨，苹果续创收盘历史新高\n美国股市周三小幅上涨，许多投资者已经预期到，奥密克戎的威胁将是可控的，这种预期推动了本周股市的连续反弹。截至收盘，道琼斯指数涨0.1%，报35754.75点；标普500指数涨0.31%，报4701.21点；纳斯达克指数涨0.64%，报15786.99点。\n热门中概股收盘大多走高，雾芯科技涨超21%\n中概股多数上涨，雾芯科技收涨超21%，好未来涨超13%，贝壳涨超11%，高途涨超11%，瑞幸咖啡涨超9%，新东方涨超8%，中通快递涨近6%；中概新能源汽车中，蔚来涨超5.8%，理想汽车涨2.1%，小鹏汽车涨超1%。\n美油收高0.4%，布油上涨0.5%\n美国原油期货价格周三创两周来的最高收盘价。关于奥密克戎变异毒株可能不会像人们担心的那样严重破坏经济的消息接踵而至，令油价持续获得支持。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格上涨31美分，涨幅0.4%，收于每桶72.36美元，创11月24日以来的最高收盘价；欧洲洲际交易所2月交割的布伦特原油期货价格上涨38美分，涨幅0.5%，收于每桶75.82美元，创11月25日以来的最高收盘价。\n黄金期货收高0.1%，并创一周来盘中最高价\n黄金期货周三小幅收高，盘中一度创一周以来新高。投资者关注奥密克戎变异毒株的发展，并等待本周即将公布的美国通胀数据。纽约商品交易所最活跃的2月黄金合约上涨80美分，涨幅不到0.1%，收于每盎司1785.50美元。盘中最高为1794.30美元，创12月1日以来的最高价格。\n欧股主要指数收跌，德国DAX30指数跌0.79%\n德国DAX30指数周三收跌0.79%，英国富时100跌0.08%，法国CAC40跌0.7%，欧洲斯托克50指数跌0.99%。\n国际宏观\n辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n辉瑞首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。\n摩根大通：2022年全球经济将全面复苏\n美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。\n世卫组织：奥密克戎毒株将显著影响全球疫情\n世卫组织总干事谭德塞表示，已有57个国家和地区出现奥密克戎毒株，预计还将继续扩散，该毒株将对全球疫情产生显著影响，但目前还难以预估具体情况。南非感染奥密克戎毒株的病例数量正在迅速增加，谭德塞呼吁各国加强监测和病毒基因测序，以了解奥密克戎毒株是否能超越德尔塔毒株成为新的主要流行毒株。\n全球芯片短缺问题未有起色，交付等待时长再创历史新高\n芯片的交付时间再度延长，这项关键产品的短缺让许多行业希望再次破灭。根据Susquehanna金融集团的最新研究结果，11月芯片的交货时长（从订购到交付）比10月的21.9周增加了4天，达到约22.3周，再创该数据有史以来最长的等待时间。\n美国职位空缺接近历史高位，“大辞职潮”近半年来首次放缓\n美国10月职位空缺数跃升至有纪录以来的次高水平，凸显出雇主在填补岗位空缺方面所面临的挑战。美国劳工部周三发布的职位空缺和劳动力流动调查报告显示，职位空缺数升至1100万，前月数据意外上修至1060万。辞职率降至2.8%。\n英国首相恢复居家工作建议 以遏制omicron传播\n英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。\n公司新闻\n苹果股价续刷历史新高，市值逼近3万亿美元\n周三苹果股价再度刷新历史高位，市值也逐步接近3万亿美元。而就在一年多前，苹果市值才刚刚突破2万亿美元大关。据悉美国法院批准苹果推迟修改应用商店规则最后期限的动议，暂停执行Epic Games反垄断诉讼中针对苹果公司的应用商店禁令，该消息推动苹果股价短线拉升。\n飙涨近22%！电子烟龙头豪掷超30亿回购股票\n电子烟龙头雾芯科技12月8日晚间发布公告称，董事会授权一项股票回购计划，根据该计划，公司可在截至2023年12月31日的一段时间内回购至多5亿美元（折合人民币31.7亿元）的股票。受此消息影响，雾芯科技股价高开高走，截至收盘，涨近22%。\n辉瑞：加强针疫苗可中和奥密克戎毒株\n辉瑞和BioNTech公司宣布，加强针新冠疫苗能中和奥密克戎变异毒株。初步试验数据显示，尽管两剂疫苗阻断奥密克戎的效果明显较差，但接种第三剂疫苗后，针对该毒株的抗体水平提高了25倍，足以和两剂疫苗对原始毒株的效果相媲美。\n阿斯利康Evusheld疫苗获得美国食品药品监督管理局紧急使用授权\n周三阿斯利康的新冠注射剂Evusheld获得美国食品药品监督管理局紧急使用授权。FDA表示，此前针对阿斯利康的新冠注射剂Evusheld发布的紧急使用授权，是为了帮助特定的成人和儿童抵御新冠病毒。\n谷歌和Roku达成新协议 确保YouTube和YouTube TV继续发行\n据报道，ROKU和谷歌今日达成了一项新的多年合作协议，使得YouTube和YouTube TV得以在Roku平台上继续存在。两家公司并未披露新协议的条款。Roku的一名代表在一份声明中称，“这项协议对我们的共同客户来说是一个积极的进展，使Roku平台上的所有流媒体用户都可以使用YouTube和YouTube TV。”\n福特首款电动皮卡需求火爆，预订量接近20万辆\n据报道，福特汽车证实，首款电动皮卡F150 Lightning目前零售预订量已经接近20万辆。F-150 Lightning自今年9月以来一直处于试生产阶段，根据计划，将于2022年春季正式上市，预计在2022年下半年交付。\n英特尔CEO：供应链问题将持续至2023年\n英特尔和埃森哲CEO表示，对一些公司来说，波及整个美国经济的供应链问题正在改善，但长期修复可能需要更多时间。芯片业巨头英特尔身处全球半导体短缺的风暴中心，该公司CEO基辛格预计供应链问题将持续到2023年，部分是因为建造一家新厂需要三年时间。基辛格说：“我们认为当前正是最糟糕的阶段。”\n游戏驿站Q3净亏损同比扩大，盘后一度跌逾7%\n财报显示，第三季度营收12.97亿美元，市场预期11.89亿美元，去年同期10.05亿美元；第三季度净亏损1.054亿美元，市场预期净亏损3213.3万美元，去年同期1880万美元；第三季度每股亏损1.39美元，市场预期亏损0.4美元，去年同期亏损0.29美元。\nUiPath 2022财年第三季度净亏损同比扩大\n财报显示，第三季度营收2.21亿美元，市场预期2.09亿美元，去年同期1.47亿美元；第三季度净亏损1.23亿美元，市场预期净亏损6258.2万美元，去年同期净亏损7079.6万美元；第三季度每股亏损0.23美元，市场预期亏损0.14美元，去年同期亏损0.41美元。","news_type":1,"symbols_score_info":{".IXIC":0.9,"AAPL":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1094,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602863179,"gmtCreate":1639007678270,"gmtModify":1639007678419,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602863179","repostId":"2190695448","repostType":2,"isVote":1,"tweetType":1,"viewCount":1084,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603381100,"gmtCreate":1638366343580,"gmtModify":1638366343893,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Buy more RBLX","listText":"Buy more RBLX","text":"Buy more RBLX","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603381100","repostId":"1181644709","repostType":2,"repost":{"id":"1181644709","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638284868,"share":"https://www.laohu8.com/m/news/1181644709?lang=zh_CN&edition=full","pubTime":"2021-11-30 23:07","market":"us","language":"en","title":"Gaming stocks jumped in morning trading<blockquote>博彩股早盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181644709","media":"Tiger Newspress","summary":"Gaming stocks jumped in morning trading.Roblox,Unity Software and Electronic Arts climbed between 2%","content":"<p>Gaming stocks jumped in morning trading.Roblox,Unity Software and Electronic Arts climbed between 2% and 5%.</p><p><blockquote>游戏股早盘上涨。Roblox、Unity Software和Electronic Arts上涨2%至5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/9aff3bf3e56d9e3cf17dfc21e823a602\" tg-width=\"399\" tg-height=\"365\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gaming stocks jumped in morning trading<blockquote>博彩股早盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGaming stocks jumped in morning trading<blockquote>博彩股早盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-30 23:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Gaming stocks jumped in morning trading.Roblox,Unity Software and Electronic Arts climbed between 2% and 5%.</p><p><blockquote>游戏股早盘上涨。Roblox、Unity Software和Electronic Arts上涨2%至5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/9aff3bf3e56d9e3cf17dfc21e823a602\" tg-width=\"399\" tg-height=\"365\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"U":"Unity Software Inc.","EA":"艺电","RBLX":"Roblox Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181644709","content_text":"Gaming stocks jumped in morning trading.Roblox,Unity Software and Electronic Arts climbed between 2% and 5%.","news_type":1,"symbols_score_info":{"U":0.9,"RBLX":0.9,"EA":0.9}},"isVote":1,"tweetType":1,"viewCount":944,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872330332,"gmtCreate":1637417286543,"gmtModify":1637417286648,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872330332","repostId":"2184984959","repostType":4,"isVote":1,"tweetType":1,"viewCount":1059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878616362,"gmtCreate":1637189176196,"gmtModify":1637189176196,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878616362","repostId":"2184885563","repostType":2,"isVote":1,"tweetType":1,"viewCount":1410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873926549,"gmtCreate":1636847981430,"gmtModify":1636847981529,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873926549","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":859350015,"gmtCreate":1634657410599,"gmtModify":1634657410709,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good good","listText":"Good good","text":"Good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/859350015","repostId":"1159487757","repostType":4,"isVote":1,"tweetType":1,"viewCount":559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829901778,"gmtCreate":1633447167203,"gmtModify":1633447189465,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/829901778","repostId":"1187887420","repostType":4,"repost":{"id":"1187887420","kind":"news","pubTimestamp":1633444673,"share":"https://www.laohu8.com/m/news/1187887420?lang=zh_CN&edition=full","pubTime":"2021-10-05 22:37","market":"us","language":"en","title":"Chief Studios Officer Of Electronic Arts Sold $440K In Stock<blockquote>Electronic Arts首席工作室官出售44万美元库存</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187887420","media":"Benzinga","summary":"Laura Miele, Chief Studios Officer at Electronic Arts(NASDAQ:EA), made a large insider sell on Octob","content":"<p><div> Laura Miele, Chief Studios Officer at Electronic Arts(NASDAQ:EA), made a large insider sell on October 1, according to a new SEC filing. What Happened:A Form 4 filing from theU.S. Securities and ...</p><p><blockquote><div>根据一份新的SEC文件，艺电（纳斯达克股票代码：EA）首席工作室官Laura Miele于10月1日进行了大规模内幕抛售。发生了什么：来自美国的表格4文件。证券和...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/10/23241376/chief-studios-officer-of-electronic-arts-sold-440k-in-stock\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/10/23241376/chief-studios-officer-of-electronic-arts-sold-440k-in-stock\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chief Studios Officer Of Electronic Arts Sold $440K In Stock<blockquote>Electronic Arts首席工作室官出售44万美元库存</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChief Studios Officer Of Electronic Arts Sold $440K In Stock<blockquote>Electronic Arts首席工作室官出售44万美元库存</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-10-05 22:37</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Laura Miele, Chief Studios Officer at Electronic Arts(NASDAQ:EA), made a large insider sell on October 1, according to a new SEC filing. What Happened:A Form 4 filing from theU.S. Securities and ...</p><p><blockquote><div>根据一份新的SEC文件，艺电（纳斯达克股票代码：EA）首席工作室官Laura Miele于10月1日进行了大规模内幕抛售。发生了什么：来自美国的表格4文件。证券和...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/10/23241376/chief-studios-officer-of-electronic-arts-sold-440k-in-stock\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/10/23241376/chief-studios-officer-of-electronic-arts-sold-440k-in-stock\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/10/23241376/chief-studios-officer-of-electronic-arts-sold-440k-in-stock\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EA":"艺电"},"source_url":"https://www.benzinga.com/news/21/10/23241376/chief-studios-officer-of-electronic-arts-sold-440k-in-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187887420","content_text":"Laura Miele, Chief Studios Officer at Electronic Arts(NASDAQ:EA), made a large insider sell on October 1, according to a new SEC filing.\nWhat Happened:A Form 4 filing from theU.S. Securities and Exchange Commission on Friday showed that Miele sold 3,100 shares of Electronic Arts at prices ranging from $140.72 to $143.81. The total transaction amounted to $441,584.\nFollowing the transaction, Miele still owns 23,632 shares of the company, worth $3,411,633.\nElectronic Arts shares are trading up 0.84% at $144.37 at the time of this writing on Tuesday morning.","news_type":1,"symbols_score_info":{"EA":0.9}},"isVote":1,"tweetType":1,"viewCount":580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859155747,"gmtCreate":1634682772319,"gmtModify":1634682818653,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/859155747","repostId":"1113211293","repostType":4,"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879083600,"gmtCreate":1636670798998,"gmtModify":1636670799192,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879083600","repostId":"1152431554","repostType":4,"repost":{"id":"1152431554","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636642592,"share":"https://www.laohu8.com/m/news/1152431554?lang=zh_CN&edition=full","pubTime":"2021-11-11 22:56","market":"us","language":"en","title":"Disney shares fell more than 8% in morning trading<blockquote>迪士尼股价早盘下跌逾8%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152431554","media":"Tiger Newspress","summary":"Atlantic Equities is cutting Disney to Neutral from Buy in the wake of its earnings, pointing to direct-to-consumer additionsslowing more than expected.It is lowering its price target to $172 from $219 per share, just below the last closing price.\"Disney's focus on franchises led to excellent sign-up rates out of the gate, but we are increasingly convinced that the penetration of this fan base is close to saturated in launched markets,\" analyst Hamilton Faber writes in a note.\"While there are ne","content":"<p>Disney&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;morning&nbsp;trading.<img src=\"https://static.tigerbbs.com/17f05b19cd1d11648dfa9756186272f4\" tg-width=\"874\" tg-height=\"611\" width=\"100%\" height=\"auto\"></p><p><blockquote>迪士尼股价早盘下跌逾8%。</blockquote></p><p> Atlantic Equities is cutting Disney&nbsp;to Neutral from Buy in the wake of its earnings, pointing to direct-to-consumer additionsslowing more than expected.</p><p><blockquote>在迪士尼公布财报后，大西洋股票公司将迪士尼从买入下调至中性，指出直接面向消费者的增长放缓幅度超出预期。</blockquote></p><p> It is lowering its price target to $172 from $219 per share, just below the last closing price.</p><p><blockquote>该公司将目标价从每股219美元下调至172美元，略低于上次收盘价。</blockquote></p><p> \"Disney's focus on franchises led to excellent sign-up rates out of the gate, but we are increasingly convinced that the penetration of this fan base is close to saturated in launched markets,\" analyst Hamilton Faber writes in a note.</p><p><blockquote>分析师汉密尔顿·费伯(Hamilton Faber)在一份报告中写道：“迪士尼对特许经营权的关注导致了出色的签约率，但我们越来越相信，这一粉丝群在已推出市场的渗透率已接近饱和。”</blockquote></p><p> \"While there are new geographies to come, we believe volume growth will disappoint,\" Faber says. \"We are retaining our (sum of the parts) valuation but cutting our target DTC revenue multiple from 8x to 5x.\"</p><p><blockquote>“虽然新的地区即将到来，但我们相信销量增长将令人失望，”费伯说。“我们保留（各部分之和）估值，但将目标DTC收入倍数从8倍削减至5倍。”</blockquote></p><p> Faber adds that reiterated Disney+ subscriber guidance of 230-260M subs for 2024 looks aggressive and he is cutting his estimate slightly to 218M.</p><p><blockquote>Faber补充说，重申的2024年Disney+订阅用户指导为2.3亿至2.6亿，看起来很激进，他将预期小幅下调至2.18亿。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disney shares fell more than 8% in morning trading<blockquote>迪士尼股价早盘下跌逾8%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisney shares fell more than 8% in morning trading<blockquote>迪士尼股价早盘下跌逾8%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-11 22:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Disney&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;morning&nbsp;trading.<img src=\"https://static.tigerbbs.com/17f05b19cd1d11648dfa9756186272f4\" tg-width=\"874\" tg-height=\"611\" width=\"100%\" height=\"auto\"></p><p><blockquote>迪士尼股价早盘下跌逾8%。</blockquote></p><p> Atlantic Equities is cutting Disney&nbsp;to Neutral from Buy in the wake of its earnings, pointing to direct-to-consumer additionsslowing more than expected.</p><p><blockquote>在迪士尼公布财报后，大西洋股票公司将迪士尼从买入下调至中性，指出直接面向消费者的增长放缓幅度超出预期。</blockquote></p><p> It is lowering its price target to $172 from $219 per share, just below the last closing price.</p><p><blockquote>该公司将目标价从每股219美元下调至172美元，略低于上次收盘价。</blockquote></p><p> \"Disney's focus on franchises led to excellent sign-up rates out of the gate, but we are increasingly convinced that the penetration of this fan base is close to saturated in launched markets,\" analyst Hamilton Faber writes in a note.</p><p><blockquote>分析师汉密尔顿·费伯(Hamilton Faber)在一份报告中写道：“迪士尼对特许经营权的关注导致了出色的签约率，但我们越来越相信，这一粉丝群在已推出市场的渗透率已接近饱和。”</blockquote></p><p> \"While there are new geographies to come, we believe volume growth will disappoint,\" Faber says. \"We are retaining our (sum of the parts) valuation but cutting our target DTC revenue multiple from 8x to 5x.\"</p><p><blockquote>“虽然新的地区即将到来，但我们相信销量增长将令人失望，”费伯说。“我们保留（各部分之和）估值，但将目标DTC收入倍数从8倍削减至5倍。”</blockquote></p><p> Faber adds that reiterated Disney+ subscriber guidance of 230-260M subs for 2024 looks aggressive and he is cutting his estimate slightly to 218M.</p><p><blockquote>Faber补充说，重申的2024年Disney+订阅用户指导为2.3亿至2.6亿，看起来很激进，他将预期小幅下调至2.18亿。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152431554","content_text":"Disney shares fell more than 8% in morning trading.\nAtlantic Equities is cutting Disney to Neutral from Buy in the wake of its earnings, pointing to direct-to-consumer additionsslowing more than expected.\nIt is lowering its price target to $172 from $219 per share, just below the last closing price.\n\"Disney's focus on franchises led to excellent sign-up rates out of the gate, but we are increasingly convinced that the penetration of this fan base is close to saturated in launched markets,\" analyst Hamilton Faber writes in a note.\n\"While there are new geographies to come, we believe volume growth will disappoint,\" Faber says. \"We are retaining our (sum of the parts) valuation but cutting our target DTC revenue multiple from 8x to 5x.\"\nFaber adds that reiterated Disney+ subscriber guidance of 230-260M subs for 2024 looks aggressive and he is cutting his estimate slightly to 218M.","news_type":1,"symbols_score_info":{"DIS":0.9}},"isVote":1,"tweetType":1,"viewCount":463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843317532,"gmtCreate":1635808539612,"gmtModify":1635808539667,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843317532","repostId":"2180209403","repostType":4,"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850626112,"gmtCreate":1634597890808,"gmtModify":1634597890889,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Pk","listText":"Pk","text":"Pk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/850626112","repostId":"2176120817","repostType":4,"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694356383,"gmtCreate":1641827250954,"gmtModify":1641827251130,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694356383","repostId":"1130016333","repostType":4,"repost":{"id":"1130016333","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641826618,"share":"https://www.laohu8.com/m/news/1130016333?lang=zh_CN&edition=full","pubTime":"2022-01-10 22:56","market":"us","language":"en","title":"Semiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1130016333","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading. Nvidia, AMD, ASML, Qualcomm, STMicroelectronics fell","content":"<p><html><head></head><body>Semiconductor stocks dipped in morning trading. Nvidia, <a href=\"https://laohu8.com/S/AMD\">AMD</a>, ASML, <a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>, STMicroelectronics fell between 1% and 6%.</p><p><blockquote><html><head></head><body>半导体股早盘下跌。英伟达，<a href=\"https://laohu8.com/S/AMD\">AMD</a>,阿斯麦,<a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>、意法半导体跌幅在1%-6%之间。</body></html></blockquote></p><p><img src=\"https://static.tigerbbs.com/7194f4d04dede76c6c5e8c137084e2af\" tg-width=\"1021\" tg-height=\"635\" referrerpolicy=\"no-referrer\"/></p><p><blockquote></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor Stocks Dipped in Morning Trading<blockquote>半导体股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-10 22:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Semiconductor stocks dipped in morning trading. Nvidia, <a href=\"https://laohu8.com/S/AMD\">AMD</a>, ASML, <a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>, STMicroelectronics fell between 1% and 6%.</p><p><blockquote><html><head></head><body>半导体股早盘下跌。英伟达，<a href=\"https://laohu8.com/S/AMD\">AMD</a>,阿斯麦,<a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a>、意法半导体跌幅在1%-6%之间。</body></html></blockquote></p><p><img src=\"https://static.tigerbbs.com/7194f4d04dede76c6c5e8c137084e2af\" tg-width=\"1021\" tg-height=\"635\" referrerpolicy=\"no-referrer\"/></p><p><blockquote></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4534":"瑞士信贷持仓","BK4141":"半导体产品","BK4554":"元宇宙及AR概念","AMD":"美国超微公司","BK4532":"文艺复兴科技持仓","NVDA":"英伟达","BK4515":"5G概念","BK4529":"IDC概念","BK4512":"苹果概念","BK4527":"明星科技股","BK4566":"资本集团","QCOM":"高通"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130016333","content_text":"Semiconductor stocks dipped in morning trading. Nvidia, AMD, ASML, Qualcomm, STMicroelectronics fell between 1% and 6%.","news_type":1,"symbols_score_info":{"QCOM":0.9,"AMD":0.9,"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":3020,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872330332,"gmtCreate":1637417286543,"gmtModify":1637417286648,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872330332","repostId":"2184984959","repostType":4,"isVote":1,"tweetType":1,"viewCount":1059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856554302,"gmtCreate":1635204549131,"gmtModify":1635204549260,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856554302","repostId":"1163628063","repostType":4,"isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873926549,"gmtCreate":1636847981430,"gmtModify":1636847981529,"author":{"id":"3583202487304124","authorId":"3583202487304124","name":"YJ13","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583202487304124","authorIdStr":"3583202487304124"},"themes":[],"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873926549","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}